Pubblicazioni

Type-B monoamine oxidase inhibitors in neurological diseases: clinical applications based on preclinical findings

2023 - NEURAL REGENERATION RESEARCH
Alborghetti, Marika; Bianchini, Edoardo; De Carolis, Lanfranco; Galli, Silvia; Pontieri, Francesco E.; Rinaldi, Domiziana

Monoamine-Oxidase type B- Inhibitors and Cognitive Functions in Parkinson's Disease: Beyond the Primary Mechanism of Action

2022 - CURRENT NEUROPHARMACOLOGY
Rinaldi, Domiziana; Alborghetti, Marika; Bianchini, Edoardo; Sforza, Michela; Galli, Silvia; Pontieri, Francesco E

Switch from rasagiline to safinamide in fluctuating Parkinson’s disease patients. a retrospective, pilot study

2021 - NEUROLOGICAL RESEARCH
Bianchini, E.; Sforza, M.; Rinaldi, D.; Alborghetti, M.; De Carolis, L.; Della Gatta, F.; Pontieri, F. E.

Different generations of type-b monoamine oxidase inhibitors in parkinson’s disease: From bench to bedside

2019 - CURRENT NEUROPHARMACOLOGY
Alborghetti, M.; Nicoletti, F.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma